Company Medical Regenesis Srl with Fiscal Code 25333817
recorded a turnover of 2024 of
47.272,
with a net profit of
26.837
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Medical Regenesis Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
20.982
9.081
28.111
44.198
9.797
33.223
231.227
369.583
71.831
47.272
Total Income - EUR
129.101
20.722
36.694
49.815
20.813
44.030
231.227
369.583
71.831
62.132
Total Expenses - EUR
117.509
20.842
31.230
30.915
8.823
6.706
16.826
18.729
17.810
31.175
Gross Profit/Loss - EUR
11.592
-120
5.464
18.900
11.989
37.323
214.401
350.855
54.021
30.957
Net Profit/Loss - EUR
9.737
-120
5.183
18.458
11.695
36.991
210.725
347.232
53.351
26.837
Employees
3
3
4
5
1
2
2
2
2
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -33.8%, from 71.831 euro in the year 2023, to 47.272 euro in 2024.
The Net Profit decreased by -26.216 euro, from 53.351 euro in 2023, to 26.837 in the last year.
Check the financial reports for the company - Medical Regenesis Srl
Financial Rating - MEDICAL REGENESIS SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Medical Regenesis Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Medical Regenesis Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Medical Regenesis Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Medical Regenesis Srl - CUI 25333817
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
142.668
136.458
129.474
123.057
116.891
110.963
104.873
101.558
97.621
93.466
Current Assets
9.238
11.955
21.708
44.706
20.127
48.607
181.960
351.357
22.306
18.755
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
7.044
7.654
12.434
15.173
17.466
12.836
12.552
218.494
16.872
12.935
Cash
2.195
4.301
9.274
29.533
2.662
35.771
169.408
132.863
5.434
5.820
Shareholders Funds
4.439
4.274
9.384
22.582
11.737
48.506
199.548
347.273
36.032
39.514
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
42.050
144.139
59.247
69.761
62.337
60.121
38.482
56.688
35.089
39.033
Income in Advance
105.418
92.702
82.551
75.420
62.943
50.943
49.814
49.968
49.817
34.678
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8621 - 8621"
CAEN Financial Year
8621
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
18.755 euro in 2024 which includes Inventories of
0 euro, Receivables of
12.935 euro and cash availability of
5.820 euro.
The company's Equity was valued at
39.514 euro, while total Liabilities amounted to
39.033 euro.
Equity increased by 3.684 euro, from 36.032 euro in 2023, to 39.514 in 2024.
The Debt Ratio was 34.5% in the year 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Medical Regenesis Srl